Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing’s Disease
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Midnight salivary cortisol (MSC) is now recognized as a reliable index for Cushing's syndrome diagnosis but has to be validated for the follow-up of treated patients. OBJECTIVE: Our objective was to evaluate MSC for assessing the outcome of transsphenoidal surgery (TSS) in patients with Cushing's disease (CD). DESIGN: We conducted a retrospective cohort study in a single center. PATIENTS AND METHODS: Sixty-eight patients treated by TSS between 1996 and 2006 and followed for at least 6 months with postoperative MSC were included. Mean follow-up (+/- sd) was 45 +/- 31 months. Morning plasma cortisol was determined 5 d after TSS, and MSC and urinary cortisol (UC) were determined 6-12 months after surgery. The remission group included hypocortisolic (morning plasma cortisol < 50 ng/ml and/or insufficient response to cosyntropin) and eucortisolic (midnight plasma cortisol < 75 ng/ml and normal UC) patients. Patients in the treatment failure group had high midnight plasma cortisol and UC concentrations. RESULTS: Fifty patients (74%) were in remission. Mean MSC was 0.7 +/- 0.4 ng/ml (range, 0.4-2.1 ng/ml) and 6.5 +/- 6.5 ng/ml (range, 2.1-27.2 ng/ml) for the remission and treatment failure groups, respectively (P = 0.001). A cutoff of 2 ng/ml for MSC gave a sensitivity of 100% and a specificity of 98% for treatment failure diagnosis, whereas UC less than 90 microg/d had a sensitivity of 71% and specificity of 98%. Postsurgical morning plasma cortisol less than or equal to 18 ng/ml had a sensitivity of 93% and specificity of 74%. CONCLUSIONS: MSC is a simple, robust marker of remission after TSS for CD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as many as 30% to 50% of CD patients will have either persistent or recurrent hypercortisolism after initial pituitary surgery [78-81]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [80]
In the citing paper
“loss of the nadir of cortisol secretion late at night is the earliest detectable biochemical abnormality in patients with recurrent CD often preceding elevations of urine cortisol or an abnormal low-dose DST [78, 80, 82, 83]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [80]
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationTreatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Self-citationThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results
Hammer, G. D., Tyrrell, J. B., Lamborn, K. R., Applebury, C. B., Hannegan, E. T., Bell, S., Rahl, R., Lu, A., & Wilson, C. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032180 · Cited by 374
The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States
Newell-Price, J. D. C. (1998) · Endocrine Reviews · doi:10.1210/er.19.5.647 · Cited by 360
Trainer, P. J., Lawrie, H. S., Verhelst, J., Howlett, T. A., Lowe, D. G., Grossman, A. B., Savage, M. O., Afshar, F., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00975.x · Cited by 267
Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
Papanicolaou, D. A., Mullen, N., Kyrou, I., & Nieman, L. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020534 · Cited by 241
Yap, L. B., Turner, H. E., Adams, C. B. T., & Wass, J. A. H. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01444.x · Cited by 203
Research works printed but not linked: 1
- Grinspoon, 1994, Laboratory assessment of adrenal insufficiency., J Clin Endocrinol Metab, 79, 923
Cited by
Bertagna, X., Guignat, L., Groussin, L., & Bertherat, J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 222
Self-citationCushing's disease: pathobiology, diagnosis, and management
Lonser, R. R., Nieman, L., & Oldfield, E. H. (2017) · Journal of Neurosurgery · doi:10.3171/2016.1.jns152119 · Cited by 215
“10,14,56,58 Recent data indicate that a morning serum cortisol level less than 1 m g/dl (on postoperative Day 3, 4, or 5 off of exogenous steroids) is the best predictor of lasting biochemical remission (96% positive predictive value).”
BackgroundTritos, N. A., Biller, B. M. K., & Swearingen, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.12 · Cited by 208
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Baudry, C., Coste, J., Bou Khalil, R., Silvera, S., Guignat, L., Guibourdenche, J., Abbas, H., Legmann, P., Bertagna, X., & Bertherat, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0358 · Cited by 187
Self-citationUtility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186
Metadata
- Authors
- Carrasco, C. A., Coste, J., Guignat, L., Groussin, L., Dugué, M. A., Gaillard, S., Bertagna, X., & Bertherat, J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Service de Biostatistique (J.C.), Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France
- Hôpital Cochin (FR)
- Service d’Hormonologie (M.A.D.), Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France
- Hôpital Foch (FR)
- Service des Maladies Endocriniennes et Métaboliques, Centre de Référence de Maladies Rares des surrénales (C.A.C., L.Gu., L.Gr., X.B., J.B.), Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-12-01
- Volume
- 93
- Issue
- 12
- Pages
- 4728-4734
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2072627847
- Cited by
- 83
- References
- 41
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 10 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 5
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's disease, transsphenoidal surgery, postoperative remission, treatment failure, urinary cortisol, ACTH stimulation test
- MeSH terms
- Adult, Female, Follow-Up Studies, Humans, Hydrocortisone, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, ROC Curve, Saliva, Treatment Outcome, Neurosurgical Procedures, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing’s Disease. https://app.cochat.ai/papers/10.1210/jc.2008-1171
- The paper
- Carrasco, C. A., Coste, J., Guignat, L., Groussin, L., Dugué, M. A., Gaillard, S., Bertagna, X., & Bertherat, J. (2008). Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-1171
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.